MCADD 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery
September 14-16, 2023
Chemical Biology of Molecules
- Chemical Biological Relationships
- Chemical Genomics
- Chemical Pharmacology
The design and production of physiologically active compounds is the focus of medicinal chemistry. Its goal is to develop new chemical structures that will help researchers better understand and alter physiological and/or pathological systems. It enables for the identification and optimization of innovative medications to fulfil unmet medical requirements in the end. The study of chemical and biochemical rationales for drug design and development is emphasised in Chemical Biology and Medicinal Chemistry. They use current structural chemistry, biotechnology, and molecular biology techniques to a wide range of fields, including analytical chemistry, biochemistry, molecular biology, organic chemistry, and pharmacology. Chemical biology and medicinal chemistry research span a wide range of topics, from the development of chemical tools to support and enhance basic biology to the application of knowledge in drug development.
- Synthesis
- Bioinformatics
- Nucleic Acid Chemistry
- Amino Acid Chemistry
- Heterocyclic Chemistry
- Biophysical Chemistry
- NMR spectroscopy
Submit your abstract Today
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt